Data protection Impressum

Life sciences

Researchers at the University of Bern and the Bern University Hospital have developed a new test that simplifies and improves the accuracy of allergy diagnosis.

Allergy test developed by Bern researchers shows higher accuracy in diagnosing food allergies

15 October 2024

Lymphatica Medtech, a Lausanne-based clinical-stage company specializing in innovative treatments for lymphedema, has raised EUR 17.9 million in a Series B funding round.

Lymphatica Medtech secures EUR 17.9 million to advance lymphedema treatment

15 October 2024

machineMD has received EU-MDR Class IIa certification for its neos™ neuro-ophthalmic diagnostic device, setting a new standard for eye movement and pupil function assessment in neurology and ophthalmology.

machineMD’s neos receives EU-MDR Class IIa Certification to advance neuro-ophthalmic diagnostics

14 October 2024

Atinary Technologies and Snapdragon Chemistry, a Cambrex company, have announced a strategic collaboration to integrate AI-driven process optimization technology with advanced pharmaceutical development capabilities, aiming to revolutionize drug development.

Atinary Technologies and Snapdragon Chemistry partner to optimize drug development with AI

9 October 2024

The newly inaugurated Genolier Innovation Hub, a 270,000-square-foot facility, offers companies, researchers and healthcare professionals an interdisciplinary platform to foster medical breakthroughs, backed by a CHF 100 million investment.

The Genolier Innovation Hub, a cutting-edge medical innovation center, was inaugurated

30 September 2024

A Memorandum of Understanding (MOU) between KoreaBIO and the Switzerland Innovation Park West EPFL was signed during the Korea-Switzerland Partnering Day, strengthening industrial cooperation and joint research in biotech.

Switzerland strengthens biotech collaboration with KoreaBIO through new MOU

30 September 2024

ten23 health celebrates the opening of its VIVA2® facility in Visp, increasing the region's sterile pharmaceutical production capacity and strengthening its position in the life sciences sector.

ten23 health inaugurates VIVA2 sterile production facility in Visp

24 September 2024

Novostia has raised CHF 5.6 million in a new financing round and appointed Soad El Ghazouani as CEO to accelerate the development of its TRIFLO heart valve technology.

Novostia secures CHF 5.6 million to accelerate the development of its heart valve

24 September 2024

Neo Medical has raised USD 68 million in a Series B financing round to accelerate the global growth of its AI-driven spine surgery solutions, with a focus on the US market.

Neo Medical secures USD 68 million to expand its AI-powered spine surgery platform

24 September 2024

The CHUV in Lausanne has inaugurated the state-of-the-art Swiss BioMotion Lab, which offers innovative solutions for the study and treatment of osteoarthritis through cutting-edge motion analysis.

CHUV inaugurates Swiss BioMotion Lab for advanced osteoarthritis research and treatment

23 September 2024

1 … 4 5 6 7 8 9 10 11 12 … 42